MAPT and Alzheimer disease: Additional studies with longitudinal follow up, larger sample sizes, and the addition of Amyloid and Tau PET scans are needed to further investigate the mechanisms leading to alterations in cortical excitability and loss of the protective mechanisms of CR occurring in AD.